Jane O'Halloran, MD, PhD

Jane O'Halloran, MD, PhD

Associate Professor of Medicine

Jane O’Halloran is the Associate Director of Virology at the Infectious Diseases Clinical Trial Research Unit which conducts clinical and translational research trials in HIV, PrEP, hepatitis, COVID-19, influenza, STIs, fungal infections, vaccines, microbiome and other infectious disease.  IDCRU has been an AIDS Clinical Trials Site since 1987.

Dr. O’Halloran specializes in clinical and translational research in infectious disease, with a special focus on HIV, SARS-CoV-2 and other viral infections. She attends on the General ID consult services teaching fellows, residents, and students. She sees patients weekly in virology clinic with a special interest in HIV.

She is currently mentoring fellows in studies on comorbidities of HIV as well as COVID-19 translation and clinical trials.

Related Links
Patients seen at

Infectious Diseases Clinic
620 South Taylor Ave., Suite 100
St. Louis, MO 63110

Additional Titles
  • Associate Director of Virology, Infectious Diseases Clinical Trial Research Unit
  • Fellowship, Infectious Diseases/HIV: Washington University School of Medicine, St. Louis MO (2019)
  • PhD – Mechanism of Cardiovascular Disease in HIV: University College Dublin, Dublin, Ireland (2016)
  • Medical Degree: National University of Ireland, Galway, Ireland (2006)
  • 2017: Young Investigator Award for 24th Conference on Retroviruses and Opportunistic Infections, Seattle
  • 2016: Young Investigator Award for 23nd Conference on Retroviruses and Opportunistic Infections, Boston
  • 2015: Young Investigator Award for 22nd Conference on Retroviruses and Opportunistic Infections, Seattle
Selected Publications
  1. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses JS Turner, JA O’Halloran, E Kalaidina, W Kim, AJ Schmitz, JQ Zhou, T Lei, …Nature 596 (7870), 109-113
  2. Switching from abacavir to tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet–collagen interactions. JA O’Halloran, E Dunne, W Tinago, S Denieffe, D Kenny, PWG Mallon. Aids 32 (7), 861-866.
  3. Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors JA O’HALLORAN, SA Cooley, JF Strain, A Boerwinkle, R Paul, RM Presti, …AIDS (London, England) 33 (9), 1477

Bibliography – Jane O’Halloran